NORWALK, Conn. - IMS Health, which provides market research to the pharmaceutical and health care industries, on Monday said second-quarter profit rose nearly 6 percent helped by strong results in its consulting and services business.
| RX | 10.73 |
Profit rose to $77.7 million, or 42 cents per share, from $73.4 million, or 36 cents per share, a year earlier.
Sales rose nearly 12 percent to $600.7 million from $537.5 million.
Analysts polled by Thomson Financial expected 40 cents per share and sales of $593.4 million.
The recent quarter included a $36 million provision for income taxes, compared with a $39.2 million provision for income taxes a year earlier.
Total operating expenses rose to $469.3 million from $419.3 million a year earlier.
When adjusted for foreign exchange hedge gains and losses and tax benefits in the second quarter of 2007, earnings per share rose a penny to 40 cents per share.
David R. Carlucci, the company's chairman and chief executive, said results were helped by growth in the company's consulting and services business, contributions from emerging markets, and cost controls.
"Led by 26 percent growth in our consulting and services business and accelerating results in the emerging markets, IMS delivered a very solid quarter," Carlucci said in a statement.
Citigroup Inc. shares tumbled below $5 a share Thursday to their lowest level in...
As more Americans rely on charity amid worsening economic gloom, operators of fo...
As many as 2,444 employees at ArcelorMittal's steel plant could be laid off indefinitely in January, the company said. The company has notified t...


Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish
Split Big Profits! You Find it & We Fund it! Co-Own Or Cash Out! Get Free Info Kit Now!
Get your next web design project done with our los angeles web design team - Best web design with great price.